Huang Xiaoming, Jia Zhenyu
Institute of Hygiene, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang 310013, P.R. China.
Exp Ther Med. 2013 Jul;6(1):209-215. doi: 10.3892/etm.2013.1111. Epub 2013 May 14.
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, particularly in developing countries. Despite the achievements in clinical therapeutics, the HCC mortality rate remains high. A number of artificial microRNA (amiRNA)-based HCC gene therapy studies have demonstrated significant inhibition of invasion and induction of apoptosis of HCC cancer cells, indicating that this type of therapy may be a promising alternative to current therapeutics. Since the structure of the amiRNA precursor in the specific intracellular environment is critical for the processing to mature amiRNA, a precursor structure that may be efficiently processed is desired. In this study, we constructed amiRNAs targeting firefly luciferase with the precursor structures of six HCC-abundant microRNAs: miR-18a, miR-21, miR-192, miR-221, miR-222 and miR-224, and evaluated the processing efficiency of these amiRNAs in the HCC cell lines Hep3B and HepG2 using a luciferase reporter system. The results demonstrated that these amiRNA precursors are capable of being expressed in HCC cells, with the miR-221 precursor-based amiRNA exhibiting the most efficient inhibition on firefly luciferase at the levels of mRNA and protein activity. This finding provides a basis for constructing HCC-targeting amiRNAs with potent processing efficiency using the precursor structure of miR-221.
肝细胞癌(HCC)是全球最常见的恶性肿瘤之一,在发展中国家尤为如此。尽管临床治疗取得了进展,但HCC的死亡率仍然很高。一些基于人工微小RNA(amiRNA)的HCC基因治疗研究已证明对HCC癌细胞的侵袭有显著抑制作用,并能诱导其凋亡,这表明这种治疗方式可能是当前治疗方法的一种有前景的替代方案。由于特定细胞内环境中amiRNA前体的结构对于加工成成熟amiRNA至关重要,因此需要一种可能被有效加工的前体结构。在本研究中,我们构建了靶向萤火虫荧光素酶的amiRNA,其具有六种HCC高表达微小RNA(miR-18a、miR-21、miR-192、miR-221、miR-222和miR-224)的前体结构,并使用荧光素酶报告系统评估了这些amiRNA在HCC细胞系Hep3B和HepG2中的加工效率。结果表明,这些amiRNA前体能够在HCC细胞中表达,基于miR-221前体的amiRNA在mRNA和蛋白质活性水平上对萤火虫荧光素酶表现出最有效的抑制作用。这一发现为利用miR-221的前体结构构建具有高效加工效率的靶向HCC的amiRNA提供了依据。